NORLUTATE DIN 00023760
Health Canada record
| Active ingredient(s) | NORETHINDRONE ACETATE 5 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | G03DC02 NORETHISTERONE |
| Original market date | 31-Dec-1961 |
| Current status date | 14-Oct-2022 |
| Source | Health Canada DPD |
Establishment licence of the holder
Searchlight Pharma Inc — licence 102247, currently licensed, last inspection rating C (2024-10-10).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing NORETHINDRONE ACETATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02553481 | ELFY | APOTEX INC | Tablet | NORETHINDRONE ACETATE 1 MG; ETHINYL ESTRADIOL 10 MCG; ETHINYL ESTRADIOL 10 MCG | Marketed |
| 02417456 | LOLO | ABBVIE CORPORATION | Tablet | NORETHINDRONE ACETATE 1 MG; ETHINYL ESTRADIOL 10 MCG; ETHINYL ESTRADIOL 10 MCG | Marketed |
| 02242531 | FEMHRT | WARNER CHILCOTT CANADA CO | Tablet | NORETHINDRONE ACETATE 1 MG; ETHINYL ESTRADIOL 5 MCG | Cancelled Post Market |
| 00353027 | LOESTRIN 1.5/30 | ALLERGAN INC | Tablet | NORETHINDRONE ACETATE 1.5 MG; ETHINYL ESTRADIOL 30 MCG | Cancelled Post Market |
| 00315966 | MINESTRIN 1/20 | ALLERGAN INC | Tablet | NORETHINDRONE ACETATE 1 MG; ETHINYL ESTRADIOL 20 MCG | Cancelled Post Market |
| 00343838 | MINESTRIN 1/20 | ALLERGAN INC | Tablet | NORETHINDRONE ACETATE 1 MG; ETHINYL ESTRADIOL 20 MCG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 29208 | 2022-10-14 | New Drug Submission (NDS) | Administrative: Change in Product Ownership |
| 11697 | 2010-08-31 | Supplement to a New Drug Submission (SNDS) | Reactivation of DIN |
| 7300 | 2005-08-18 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 2488 | 2001-01-17 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
International API supply for NORETHINDRONE ACETATE
7 active FDA Drug Master Files.
Request a quote for NORLUTATE